OB/GYN and Women's Health - Global Oncology Academy

17-32 of 115

Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Clinician's Roundtable
Adherence to OB/GYN-Ordered CRC Screening: Real-World Insights
Mallik Greene, PhD
- Mallik Greene, PhD
Streamlining Colorectal Cancer Screening in OB/GYN Care
Streamlining Colorectal Cancer Screening in OB/GYN Care
Clinician's Roundtable
Streamlining Colorectal Cancer Screening in OB/GYN Care
Jemel Bingham, MD
- Jemel Bingham, MD
How Colorectal Cancer Screening Fits into OB/GYN Care
How Colorectal Cancer Screening Fits into OB/GYN Care
Clinician's Roundtable
How Colorectal Cancer Screening Fits into OB/GYN Care
Mallik Greene, PhD
- Mallik Greene, PhD
Protecting Heart Health in Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
The Past, Present, and Future of Metastatic Breast Cancer Care
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
The Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Decoding Co-Mutations in HR+, HER2- Metastatic Breast Cancer
Abirami Sivapiragasam
- Abirami Sivapiragasam
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Project Oncology®
Assessing G-CSF Prophylaxis with Sacituzumab Govitecan in mTNBC
Charles Turck, PharmD, BCPS, BCCCP; Kelly McCann, MD, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- Kelly McCann, MD, PhD
- Gregory Vidal, MD, PhD
Addressing Unmet Needs in First-Line mTNBC Care
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast Cancer
Addressing Unmet Needs in First-Line mTNBC Care
Jennifer Caudle, DO, FACOFP; Alexis Ann LeVee, MD
- Jennifer Caudle, DO, FACOFP
- Alexis Ann LeVee, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Maxwell Llyod, MD; Ryan Quigley
- Maxwell Llyod, MD
- Ryan Quigley
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Project Oncology®
How the First Metastatic Site Shapes Survival in Breast Cancer Relapse
Ryan Quigley
- Ryan Quigley
Does BMI Matter in mBC Outcomes?
Does BMI Matter in mBC Outcomes?
Project Oncology®
Does BMI Matter in mBC Outcomes?
Predicting Breast Cancer Metastasis with Proteomics
Predicting Breast Cancer Metastasis with Proteomics
Project Oncology®
Predicting Breast Cancer Metastasis with Proteomics
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
Project Oncology®
Longitudinal Biopsies in mBC Map Immune Response to HER2 Tri-Blockade
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
Project Oncology®
What Rapid Autopsies Reveal About Metastatic Breast Cancer Biology
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP; Heather Parsons
- Charles Turck, PharmD, BCPS, BCCCP
- Heather Parsons
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling
Project Oncology®
Tracking Early Immunotherapy Response in mTNBC Using cfDNA-Based Copy-Number Profiling

2/7